News
FDA approves Amgen’s IMDELLTRA for the treatment of extensive-stage small cell lung cancer
The U.S. Food and Drug Administration (FDA) has approved Amgen's IMDELLTRA™ (tarlatamab-dlle) for the treatment of adult patients with extensive-stage small cell lung cancer...
Nuvalent receives U.S. FDA breakthrough therapy designation for NVL-655
The U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation (BTD) to Nuvalent's NVL-655 for the treatment of patients with locally advanced or...
Collaboration between Galapagos and Blood Centers of America to improve patient access to life-saving...
Galapagos and Blood Centers of America (BCA) have entered into a strategic collaboration for the decentralized manufacturing of Galapagos’ CAR-T cell therapies through BCA’s...
